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ABSTRACT
Eosinophil penetration across the basement mem-
brane (BM) is thought to be dependent on the
degradation of membrane components. In this
process, matrix metalloproteinases (MMP) appear to
be primarily responsible for degradation of the BM.
Matrix metalloproteinases -2 and MMP-9 degrade type
IV collagen, which is a major component of the BM. In
the present study, the effects of eotaxin, a selective
chemoattractant for eosinophils, on the expression of
MMP mRNA were examined. Incubation with chemo-
tactically active concentrations of eotaxin for 24 h
enhanced the expression of mRNA for membrane-type
1 MMP (MT1-MMP), but not of mRNA for MMP-2 and
MMP-9. An increase in the protein level of MT1-MMP
was also detected in the cell lysate of eotaxin-treated
eosinophils. These results suggest that up-regulation
of MT1-MMP expression may be involved in the
eotaxin-induced penetration of eosinophils.
Key words: basement membrane, degradation,
eosinophil, eotaxin, matrix metalloproteinase-2,
matrix metalloproteinase-9, membrane-type matrix
metalloproteinase.
INTRODUCTION
The accumulation of eosinophils into the sites of inflam-
mation is an important event in several allergic diseases,
including allergic rhinitis, atopic dermatitis and asthma.
In response to the stimulus of an allergic reaction,
eosinophils adhere to the endothelial cell surface of post-
capillary venules, cross the endothelium through
interendothelial cell junctions and probably penetrate the
basement membrane (BM), leaving the vascular system
to accumulate at the inflammatory site. It is therefore con-
sidered that enzymatic degradation of the BM by
eosinophils is one of the important steps in infiltration into
inflammatory sites, similar to tumor cell invasion. How-
ever, little is known about the mechanism of eosinophil
penetration through the BM, although some of the mech-
anisms by which adhesion molecules and cytokines
promote eosinophil binding to and migration through the
endothelium in allergic inflammation have been eluci-
dated.1 Degradation of the BM by eosinophils is an
important step for the inflammatory cell infiltration,
similar to tumor invasion. Several classes of proteinases,
including serine proteinases, cysteine proteinases and
matrix metalloproteinases (MMP), have been implicated
in the degradation of the extracellular matrix (ECM).2
Among these proteinases, MMP appear to be primarily
responsible for much of the ECM degradation during the
invasive process. A previous study showed that MMP-2
and MMP-9 are involved in the migration of lymphocytes
through reconstituted BM in vitro.3 Elastase and MMP-9
have also been reported to be responsible for the migra-
tion of neutrophils through the BM.4 Okada et al. have
reported that MMP-9 plays a major role in eosinophil
migration to the site of allergic inflammation.5 However,
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anti-MMP-9 antibody shows only a 50% inhibition of the
eosinophil migration induced by interleukin (IL)-5 and
platelet-activating factor (PAF). These results indicate that
some other molecules that promote the migration of
eosinophils are probably involved in this process.
In general, MMP are secreted in a latent form (pro-
MMP) and are consequently activated by serine protein-
ases or other activated MMP to an active form. A recent
study has demonstrated that proteolytic maturation of 
pro-MMP-2 is involved in a specific mechanism not involv-
ing the other tested MMP.6,7 Pro-MMP-2 activation is
mediated by membrane type 1 MMP (MT1-MMP/MMP-14)
on the cell surface, a novel MMP possessing a hydro-
phobic C-terminal transmembrane domain.8–11
In the present study, we focused our attention on the
modulation of MMP expression in eosinophils stimulated
with eotaxin, which is a potent chemoattractant for
eosinophils.
METHODS
Cell preparation
Eosinophils were purified as previously described.12
Briefly, peripheral blood polymorphonuclear leukocytes
(PMNL; containing neutrophils and eosinophils) from
whole blood of volunteer donors who had an anamnesis
for allergy were isolated by 4.5% dextran-sedimentation
followed by density-gradient centrifugation with Lymph-
ocyte Separation Medium (LSM®) (ICN Biomedicals Inc.,
Aurora, OH, USA). Then, eosinophils were negatively
collected by incubation with mouse antihuman CD16
monoclonal antibody (Nichirei Co., Tokyo, Japan) fol-
lowed by treatment with beads coupled to sheep antimouse
Ig antibody (Dynabeads, Dynal AS, Oslo, Norway). The
purity of the eosinophil population was > 96%, as assessed
by Diff-Quick staining (Baxter, Dudigen, Switzerland;
Fig. 1). The positively collected neutrophil population was
harvested by trypsinization. Peripheral blood mononuclear
cells (PBMNC) were collected from mononuclear cell
fraction of LSM centrifugation.
Treatment of leukocytes with eotaxin
Eosinophils (5 · 106), PBMNC (5 · 106) and neutrophils
(1 · 107), suspended in RPMI-1640 + 10% fetal bovine
serum, were cultured in 12-well plates with or without
recombinant human eotaxin (100 ng/mL; Bachem Fine
Chem. AG, Bubendorf, Switzerland) for 24 h at 37° C in a
5% CO2 incubator.
Preparation of total RNA and reverse 
transcriptase–polymerase chain reaction
Total RNA was isolated from human eosinophils using
ISOGEN (Wako Chemicals, Osaka, Japan), and reverse
transcription (RT) was performed using a First-strand
cDNA Synthesis kit (Takara Biochemicals, Siga, Japan) at
42°C for 45 min to maximize cDNA synthesis and was
terminated by heating at 99°C for 5 min. Polymerase
chain reaction (PCR) was performed using cDNA tem-
plates (100 ng) and specific oligonucleotide primers with
denaturation at 94°C for 30 s, annealing for 60 s
(appropriate temperatures for each gene), and extension
at 72°C for 90 s, using TAKARA Ex Taq (Takara
Biochemicals) according to the manufacturer’s instruc-
tions. The sequences of the primers for each gene were
as follows: 5¢ -TGAAGGTCGGAGTCAACGGATTTGGT-3¢
(glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
sense),13 5 ¢ -CATGTGGGCCATGAGGTCCACCAC-3 ¢
(GAPDH antisense),13 5 ¢ -CCACGTGACAAGCC-
CATGGGGCCCC-3¢ (MMP-2 sense),14 5¢ -GGAGCCT-
AGCCAGTCGGATTTGATG-3 ¢ (MMP-2 antisense),14
5 ¢ -AACGCTATGGTTACACTCGG-3 ¢ (MMP-9 sense;
Genbank, J05070), 5¢ -AACTGGATGACGATGTCTGC-3¢
(MMP-9 antisense; GenBank, J05070), 5¢ -CCCTATGC-
CTACATCCGTGA-3¢ (MT1-MMP sense)15, 5¢ -TCCATC-
CATCACTTGGTTAT-3¢ (MT1-MMP antisense).15
The predicted PCR products were 983 bp, 480 bp,
361 bp and 550 bp for GAPDH, MMP-2, MMP-9 and
MT1-MMP, respectively. The PCR products were detected
using electrophoresis on 1.5% agarose gels (Takara
Biochemicals, Siga, Japan) and staining with ethidium
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Fig. 1 Micoscopic observation of highly purified eosinophils.
Eosinophils were purified by the procedure described in
Methods. The purity of the eosinophil preparations used in this
study was greater than 96.0%.
bromide. The relative abundance of MMP was indicated
as the density relative to that of GAPDH, determined by
using a Master Scan Gel Analysis System (Scanalytics,
Billeica, MA, USA).
Western blot analysis
Cell lysates of eosinophils were isolated using RIPA buffer
set (Boehringer Mannheim GmbH, Mannheim, Germany)
and stored at – 80°C until use. Aliquots of 10 m g protein
were electrophoresed on 10–20% gradient-polyacrylamide
gels and were blotted onto nitrocellulose filters (Bio-Rad
Laboratories, CA, USA). The filters were developed with
rabbit polyclonal antibodies specific for MT1-MMP
(Chemicon International Inc., Temecula, CA, USA), horse-
radish peroxidase-conjugated goat antirabbit antibody
(Amersham Pharmacia Biotech UK Ltd, Buckinghamshire,
England) and superSignal (Pierce Inc., Billeica, IL, USA)
detection. The density of MT1-MMP was determined by
using the Master Scan Gel Analysis System (Scanalytics).
Statistics
Two-sided Welch’s t-test was performed for the expression
of mRNA for MMP in eosinophils.
RESULTS
Increase in expression of MMP mRNA in
eotaxin-treated eosinophils
We investigated the expression of mRNA for MT1-MMP,
MMP-2 and MMP-9 in human eosinophils by RT-PCR. As
shown in Fig. 2a, expression of mRNA for MT1-MMP and
MMP-9 was detected in human eosinophils from three
donors. The expression of mRNA for MT1-MMP was
markedly enhanced by the treatment with eotaxin,
whereas that for MMP-9 was not increased. The signal of
mRNA for MMP-2 was weak both in untreated or eotaxin-
treated eosinophils. The density ratio of MT1-MMP
relative to GAPDH was increased in eotaxin-treated
eosinophils, whereas those of MMP-2 or MMP-9 were not
significantly changed (Fig. 3). To further confirm the
specificity of eotaxin-induced expression of MT1-MMP in
the eosinophils, we also examined the effect of eotaxin on
the expression of MMP mRNA in PBMNC and neu-
trophils. As shown in Fig. 2b,c and Fig. 3, the expression
of mRNA for MMP in either PBMNC or neutrophils was
not significantly affected by the treatment with eotaxin.
Detection of MT1-MMP by western blotting
Increase in the protein level of MT1-MMP in eotaxin-
treated eosinophils was examined by the western blotting
method. A marked enhancement of expression of MT1-
MMP protein was detected in eotaxin-treated eosinophils
in comparison with untreated eosinophils (Fig. 4).
DISCUSSION
Eosinophil infiltration into the site of inflammation is a
crucial step in allergic diseases. The selective accumula-
tion of eosinophils into the inflammatory site suggests
that there may be a local release of chemoattractants
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Fig. 2 Expression of mRNA for matrix metalloproteinases
(MMP) in human eosinophils, peripheral blood mononuclear
cells (PBMNC) and neutrophils. Highly purified eosinophils
(Eos.) were collected from three volunteers (a). In addition,
PBMNC (b) and neutrophils (c) were collected from volunteer
no. 1. These cells were incubated with or without eotaxin
(100 ng/mL) for 24 h. Total RNA was isolated and reverse
transcriptase polymerase chain reaction was performed. The
numbers of amplification cycles for MT1-MMP, MMP-2, MMP-9
and reduced glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were 36, 39, 36 and 30, respectively. The PCR 
products were electrophoresed on 1.5% agarose gels.
specific for these leukocytes. In particular, eotaxin, which
belongs to the C-C chemokine family, is considered to
play an important role in eosinophil infiltration. Brown
et al. have observed increased gene transcription and
production of eotaxin in the bronchial mucosa and
bronchiovascular lavage fluid (BALF) of patients with
allergic asthma compared with non-asthmatic subjects.16
The up-regulation of eotaxin expression is closely 
correlated with the number of airway eosinophils.17
Enzymatic degradation of ECM is an important step in
the process of cellular migration and invasion.18
Gelatinase A (MMP-2) and B (MMP-9) degrade the type
IV collagen and mediate the invasion of various types of
cells, such as endothelial cells, fibroblasts and
macrophages.19–22 Gelatinase secretion by tumor cells is
also correlated with their metastatic potential.23–26 In
addition, MT1-MMP regulates the proteolytic activation
of MMP-2 and also degrades type I, II and III collagens,
laminin and fibronectin by itself.27–30 Although MMP-9
has been reported to be expressed in eosinophils,5 there
are few reports on the relationship between the expres-
sion of MMP and the eosinophil-specific chemokines, for
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Fig. 3 Densitometric analysis
for the expression of matrix 
metalloproteinases (MMP) in
eosinophils, peripheral blood
mononuclear cells (PBMNC)
and neutrophils. The intensity of
MT1-MMP, MMP-2 and MMP-9
expression in untreated (h) and
eotaxin-treated (j) cells is
shown as a density ratio relative
to reduced glyceraldehyde 
3-phosphate dehydrogenase
(GAPDH). The results of eosino-
phils are the mean ± SD of
triplicate samples. *P < 0.05
(two-sided Welch’s t-test).
Fig. 4 Western blot analysis of MT1-MMP expression.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
was performed under reducing conditions. After blotting,
protein levels of MT1-MMP in eosinophils were detected using
monoclonal antibodies for MT1-MMP (a). (b) Densitometric
analysis of the expression of MT1-MMP in untreated or eotaxin-
treated eosinophils.
example, an eotaxin. Therefore, it is important to clarify
the regulatory mechanism of the enzymatic degradation
of the ECM by eosinophils. Considering the results of
clinical studies,31–33 we carried out studies to examine the
possibility that eotaxin acts, not only as a chemoattractant
for eosinophils, but also as a regulatory factor in the 
infiltration process.
In the present study, we investigated the mRNA expres-
sion of MMP in human eosinophils, because MMP are
considered to be closely involved in degradation of the
BM. Incubation with a chemotactically active con-
centration of eotaxin (100 ng/mL)34 for 24 h markedly
enhanced the expression of the mRNA for MT1-MMP in
human eosinophils, compared with MMP-2 and MMP-9
(Figs 2,3). In contrast, the expression of mRNA for MMP-2,
MMP-9 and MT1-MMP in either PBMNC or neutrophils
was not significantly affected by the treatment with
eotaxin. Thus, MT1-MMP may play a critical role in the
regulation of eotaxin-induced eosinophil infiltration.
Furthermore, it has previously been reported that the
inflammatory response in asthma results in the genera-
tion of MMP-2 from the epithelium.35 Therefore,
activation of MMP-2 at the sites of allergic inflammation
may be modulated through MT1-MMP on the eosinophil
surface.
In conclusion, the present study suggests that MT1-
MMP probably plays an important role in eotaxin-induced
eosinophil infiltration. In addition to eotaxin, other
inflammatory chemokines may also be involved in the
modulation of eosinophil invasion in a number of allergic
diseases, such as asthma and atopic dermatitis. Further
investigation will be needed to examine the mechanism
of eotaxin-induced infiltration of eosinophils.
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